Ropinirole without levodopa in Parkinson's disease
- 1 August 1990
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 336 (8710), 316-317
- https://doi.org/10.1016/0140-6736(90)91855-5
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- TREATMENT OF PARKINSON'S DISEASE WITH NOVEL DOPAMINE D2 AGONIST SK&F 101468The Lancet, 1989
- Early combination of bromocriptine and levodopa in the treatment of Parkinson's diseaseNeurology, 1987
- 4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone: a prejunctional dopamine receptor agonistJournal of Medicinal Chemistry, 1985
- Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1981
- BROMOCRIPTINE ASSOCIATED WITH A PERIPHERAL DOPAMINE BLOCKING AGENT IN TREATMENT OF PARKINSON'S DISEASEThe Lancet, 1979
- Long-term treatment of Parkinson's disease with bromocriptine.Journal of Neurology, Neurosurgery & Psychiatry, 1979
- ParkinsonismNeurology, 1967